December 2011 – Collaborators Ben Philpot, Mark Zylka and Bryan Roth identify compounds that cause the dormant Ube3a gene to be expressed.
![image2](https://www.med.unc.edu/cellbiophysio/wp-content/uploads/sites/734/2018/06/potential-treatment-strategy-for-angelman-syndrome-identified-image2.jpeg)
December 2011 – An interdisciplinary team of UNC scientists say they have found a way to “awaken” the paternal allele of Ube3a, which could lead to a potential treatment strategy for Angelman syndrome (AS). Their results were published online by the journal Nature. Read the complete UNC School of Medicine news release >>